About Careers Internship MedBlog Contact us

The Pill - Lowers Cancer Risks Over Short Term Use

by Medindia Content Team on September 13, 2007 at 2:34 PM
Font : A-A+

The Pill - Lowers Cancer Risks Over Short Term Use

Scientists opine that taking the contraceptive pill over a short period may reduce a woman's chances of getting cancer . Yet, taking it for too long may increase the risk.

The study published in the British Medical Journal says that women who take the Pill can have up to a 12 percent lower risk of developing the disease. Yet, the same research also showed women who used the pill for more than eight years - a quarter of those in the study - had a significantly higher risk of developing cancer.


The researchers from the University of Aberdeen found those who took the contraceptive for shorter periods suffered from significantly lower rates of bowel and rectal cancer, uterine cancer and ovarian cancer. Additionally, up to 29 percent had a reduced risk of developing one of the main gynecological cancers.

Those who took the pill for more than eight years had an increased risk of developing all forms of cancer, particularly cervical and central nervous system cancer, they found. Previous studies have suggested earlier forms of the Pill - which was launched in 1961 - may have increased the risk of developing the disease.

Lead researcher Professor Phillip Hannaford of the University of Aberdeen was quoted: "These results show that in this UK cohort the contraceptive pill was not associated with an overall increased risk of any cancer, indeed it may produce an important net public health gain. "These findings will probably reassure most Pill users living in the UK and their doctors."

The research happens to be one of the largest detailed studies of the Pill in the world.

Source: Medindia


Recommended Readings

Latest Cancer News

Combination Therapy may Benefit Leukemia Patients
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

The Pill - Lowers Cancer Risks Over Short Term Use Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests